IgA Type Multiple Myeloma, Clinical Features, and Prognosis
Chin Med J (Engl)
.
2018 May 20;131(10):1249-1250.
doi: 10.4103/0366-6999.231513.
Authors
Ling Wang
1
,
Feng-Yan Jin
2
,
Ying Li
1
,
Jing-Nan Sun
2
,
Jia-Jia Zhang
3
,
Ran Tang
3
,
Yu-Ping Zhong
3
Affiliations
1
Department of Haematology, Qingdao Central Hospital, Qingdao, Shandong 266042, China.
2
Department of Haematology, First Hospital of Jilin University, Changchun, Jilin 130021, China.
3
Department of Haematology, Beijing Chao-Yang Hospital (West), Capital Medical University, Beijing 100043, China.
PMID:
29722346
PMCID:
PMC5956780
DOI:
10.4103/0366-6999.231513
No abstract available
Publication types
Letter
MeSH terms
Humans
Immunoglobulin A*
Multiple Myeloma / complications
Multiple Myeloma / immunology*
Multiple Myeloma / therapy
Prognosis
Substances
Immunoglobulin A